Cartesian Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
RNAC
CUSIP
816212302
Type
Equity
Class
COM NEW
Num filings
1
Total reported value, excl. options
$1.34 k
Manager Report Date Value ($000) Shares Option Type